发明名称 |
IMMUNITY INDUCTION AGENT |
摘要 |
Provided is a novel immunity-inducing agent useful as a therapeutic and/or prophylactic agent for cancer. The immunity-inducing agent comprises as an effective ingredient(s) at least one polypeptide having immunity-inducing activity selected from the polypeptides (a), (b) and (c) below, and/or a recombinant vector(s) that comprise(s) a polynucleotide(s) encoding the at least one polypeptide, which recombinant vector(s) is/are capable of expressing the polypeptide(s) in vivo: (a) a polypeptide composed of not less than 7 consecutive amino acids in any one of the amino acid sequences of SEQ ID NOs:4, 2, 22 and 24 in SEQUENCE LISTING; (b) a polypeptide having a sequence identity of not less than 90% to the polypeptide (a) and composed of not less than 7 amino acids; and (c) a polypeptide comprising the polypeptide (a) or (b) as a partial sequence thereof. |
申请公布号 |
US2014154206(A1) |
申请公布日期 |
2014.06.05 |
申请号 |
US201214118417 |
申请日期 |
2012.05.18 |
申请人 |
Kurihara Akira;Okano Fumiyoshi |
发明人 |
Kurihara Akira;Okano Fumiyoshi |
分类号 |
C12N9/02 |
主分类号 |
C12N9/02 |
代理机构 |
|
代理人 |
|
主权项 |
1. An immunity-inducing agent comprising as an effective ingredient(s) at least one polypeptide having immunity-inducing activity selected from the polypeptides (a) to (c) below, and/or a recombinant vector(s) that comprise(s) a polynucleotide(s) encoding said at least one polypeptide, said recombinant vector(s) being capable of expressing said polypeptide(s) in vivo:
(a) a polypeptide composed of not less than 7 consecutive amino acids in any one of the amino acid sequences of SEQ ID NOs:4, 2, 22 and 24 in SEQUENCE LISTING; (b) a polypeptide having a sequence identity of not less than 85% to said polypeptide (a) and composed of not less than 7 amino acids; and (c) a polypeptide comprising said polypeptide (a) or (b) as a partial sequence thereof.
|
地址 |
Kamakura-shi JP |